Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy.
CAT No: R1116
CAS No:168650-46-2
Synonyms/Alias:168650-46-2;[Asp371]-Tyrosinase (369-377), human;2-[[5-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoic acid;2,2,2-trifluoroacetic acid;(Asp371)-Tyrosinase (369-377) (human) acetate salt;168650-46-2(free basis);H-Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH; H-YMDGTMSQV-OH;YMDGTMSQV;Asp371;Tyrosinase 369-377;FA73646;DA-69124;FA109106;FA110240;[Asp371] Tyrosinase(369-377), human;(Asp371)-Tyrosinase (369-377) (human) trifluoroacetate salt;
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More